Recombinant Didelphis marsupialis virginiana ATP synthase protein 8 (MT-ATP8)

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context

MT-ATP8 is a subunit of mitochondrial ATP synthase (Complex V), which catalyzes ATP production during oxidative phosphorylation . The recombinant version, derived from the North American opossum (Didelphis marsupialis virginiana), is engineered for experimental studies, with a full-length sequence of 69 amino acids (MPQLNTSTWTLTISLMIISLFCIYQLKMMNQTLIQITPSTEQSKLTKHTLPWEKKWTKIYLPHSSHQQF) . It is expressed in E. coli systems with tags (e.g., His-tag) for purification .

Key Features:

PropertyDetail
Molecular Weight8,209 Da
Sequence Length69 residues
Structural Motifsα-helix spanning the mitochondrial membrane
Storage ConditionsTris-based buffer with 50% glycerol; stable at -20°C/-80°C

Functional Roles in Metabolic Pathways

MT-ATP8 is integral to ATP synthase’s F<sub>O</sub> domain, stabilizing subunit interactions rather than directly participating in proton transport . It is implicated in:

Associated Pathways :

PathwayKey Partner Proteins
Oxidative phosphorylationNDUFA2, COX7A2A, ATP6V1C1
Alzheimer’s diseaseNDUFB10, COX6B1, CASP9
Metabolic pathwaysCECR1A, POLR1A, ATP5B

Research Applications

Recombinant MT-ATP8 is widely used in:

  • Western blotting (WB) and immunoprecipitation (IP) to study mitochondrial disorders .

  • Enzyme-linked immunosorbent assays (ELISA) for quantifying ATP synthase interactions .

  • Structural studies to model mutations linked to neuromuscular diseases (e.g., m.8403T>C variant) .

Example Mutational Analysis :

VariantPathogenic EffectModel System
m.8403T>CNo significant functional impairmentYeast mitochondria
Other MT-ATP8 mutationsLinked to epilepsy, cardiomyopathyHuman clinical studies

Expression and Purification :

  • Host System: E. coli with codon optimization for eukaryotic expression.

  • Purity: ≥85% (SDS-PAGE verified).

  • Formats: Lyophilized powder or liquid suspension with glycerol.

Stability Guidelines:

  • Avoid repeated freeze-thaw cycles.

  • Working aliquots stored at 4°C for ≤1 week .

Clinical and Evolutionary Significance

  • Disease Associations: Mutations in MT-ATP8 correlate with mitochondrial encephalopathies, ataxia, and cardiomyopathies due to disrupted ATP synthase assembly .

  • Evolutionary Conservation: Structural homology between yeast and mammalian subunit 8 supports cross-species functional studies .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MT-ATP8; ATP8; ATPASE8; MTATP8; ATP synthase protein 8; A6L; F-ATPase subunit 8
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-69
Protein Length
full length protein
Species
Didelphis virginiana (North American opossum) (Didelphis marsupialis virginiana)
Target Names
Target Protein Sequence
MPQLNTSTWTLTISLMIISLFCIYQLKMMNQTLIQITPSTEQSKLTKHTLPWEKKWTKIYLPHSSHQQF
Uniprot No.

Target Background

Function
Mitochondrial membrane ATP synthase (F1F0 ATP synthase or Complex V) synthesizes ATP from ADP using a proton gradient across the membrane. This gradient is generated by the respiratory chain's electron transport complexes. F-type ATPases comprise two domains: the extramembraneous catalytic core F1 and the membrane proton channel F0, linked by a central and peripheral stalk. ATP synthesis in the F1 catalytic domain is coupled to proton translocation via the central stalk's rotary mechanism. This protein is a minor subunit of the F0 domain, located within the membrane alongside subunit a.
Protein Families
ATPase protein 8 family
Subcellular Location
Mitochondrion membrane; Single-pass membrane protein.

Q&A

What is the basic structure of Didelphis marsupialis virginiana MT-ATP8?

Didelphis marsupialis virginiana MT-ATP8 is a small, hydrophobic protein consisting of 69 amino acids with the sequence: MPQLNTSTWTLTISLMIISLFCIYQLKMMNQTLIQITPSTEQSKLTKHTLPWEKKWTKIYLPHSSHQQF . As a component of the mitochondrial ATP synthase complex, it is primarily embedded in the inner mitochondrial membrane. The protein is typically expressed with an N-terminal His-tag when produced recombinantly in expression systems such as E. coli . This small subunit is crucial for the proper assembly and functioning of the ATP synthase complex.

How conserved is MT-ATP8 across species compared to the opossum version?

The MT-ATP8 protein shows varying degrees of conservation across species, reflecting both functional constraints and evolutionary divergence. While the core functional domains maintain higher conservation, the North American opossum MT-ATP8 exhibits some unique features compared to other mammals. Evolutionary analyses of MT-ATP8 sequences suggest that this gene has undergone multiple events of migration to the nuclear genome in the genus Didelphis, as evidenced by the presence of mtDNA-like sequences in the nuclear genome . This phenomenon complicates comparative analyses but provides valuable insights into mitochondrial gene evolution. Sequence alignments across marsupials and other mammals reveal conserved motifs essential for protein function while highlighting regions that may contribute to species-specific adaptations.

What are the optimal conditions for recombinant expression of Didelphis MT-ATP8?

For successful recombinant expression of Didelphis marsupialis virginiana MT-ATP8, E. coli has proven to be an effective heterologous expression system . The protein is typically expressed with an N-terminal His-tag to facilitate purification. The expression construct should contain the complete coding sequence (1-69 amino acids) of the protein. For optimal expression, consider the following methodology:

  • Vector selection: pET vectors with T7 promoter systems have shown good expression levels for membrane proteins.

  • E. coli strain: BL21(DE3) or derivatives optimized for membrane protein expression.

  • Induction conditions: Use lower IPTG concentrations (0.1-0.5 mM) and reduced temperature (16-25°C) for induction to minimize inclusion body formation.

  • Buffer optimization: Inclusion of glycerol (5-10%) and mild detergents in lysis and purification buffers helps maintain protein solubility.

  • Purification: Purify using Ni-NTA affinity chromatography followed by size exclusion chromatography.

After purification, the protein can be stored as a lyophilized powder or in solution with appropriate stabilizing agents . For reconstitution, the protein should be dissolved in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL, with 5-50% glycerol added as a cryoprotectant for long-term storage at -20°C/-80°C .

What are the challenges in studying the interactions between MT-ATP8 and other ATP synthase subunits?

Investigating the protein-protein interactions between MT-ATP8 and other ATP synthase subunits presents several methodological challenges:

  • Hydrophobicity: MT-ATP8's highly hydrophobic nature makes it difficult to maintain in solution without appropriate detergents or membrane mimetics.

  • Small size: At only 69 amino acids, MT-ATP8 is challenging to manipulate individually while maintaining its native conformation.

  • Complex assembly dynamics: ATP synthase is a multi-subunit complex with intricate assembly pathways, making it difficult to isolate specific interaction stages.

  • Functional redundancy: Some functions may be partially compensated by other subunits, complicating interpretation of interaction studies.

  • Technical limitations: Traditional techniques like co-immunoprecipitation may disrupt the native membrane environment essential for proper interactions.

Researchers have addressed these challenges using complementary approaches such as crosslinking mass spectrometry, blue native PAGE, proximity labeling techniques, and cryo-electron microscopy to capture the interactions in near-native states . Yeast models have proven particularly valuable as they allow for genetic manipulation of ATP synthase components while maintaining functional enzyme complexes that can be biochemically characterized .

How can researchers effectively analyze MT-ATP8 variants and their functional impact?

Analysis of MT-ATP8 variants requires a multi-faceted approach combining genetic, biochemical, and structural methods. Based on successful studies of MT-ATP8 variants, the following methodological framework is recommended:

This integrated approach allows for comprehensive assessment of how specific amino acid changes in MT-ATP8 affect both structure and function of the ATP synthase complex.

How can nuclear-encoded MT-ATP8-like sequences in Didelphis be distinguished from authentic mitochondrial sequences?

The presence of mtDNA-like sequences in the nuclear genome of Didelphis (nuclear mitochondrial DNA segments or NUMTs) creates significant challenges for genetic analysis . To accurately distinguish authentic mitochondrial MT-ATP8 sequences from nuclear pseudogenes, researchers should implement a multi-step methodological approach:

  • Enrichment of mitochondrial fraction: Begin with careful isolation of intact mitochondria using differential centrifugation and density gradient purification to minimize nuclear DNA contamination.

  • PCR strategy optimization:

    • Design primers in highly divergent regions between nuclear and mitochondrial copies

    • Utilize long-range PCR that exceeds the typical size of nuclear insertions

    • Implement touchdown PCR protocols with high stringency conditions

  • Sequence analysis parameters:

    • Examine patterns of sequence evolution (nuclear pseudogenes typically show different mutation patterns)

    • Calculate transition/transversion ratios (typically higher in authentic mtDNA)

    • Analyze codon usage patterns characteristic of mitochondrial genes

    • Check for the presence of mitochondrial genetic code features

  • Phylogenetic approaches: Compare sequences with known mitochondrial and nuclear references. Nuclear copies often appear as distinct clusters or show unusual branch lengths in phylogenetic trees .

  • Functional validation: Express suspected authentic sequences and test for proper mitochondrial targeting and incorporation into ATP synthase complexes.

Research has shown that mtDNA migration to the nuclear genome occurred multiple times during Didelphis evolution, resulting in paralogous sequences of different ages with varying degrees of divergence from authentic mitochondrial genes .

What potential exists for using recombinant MT-ATP8 in allotopic expression research?

Allotopic expression—the nuclear expression of mitochondrially encoded genes with targeting back to mitochondria—represents a promising approach for addressing mitochondrial genetic defects. Research with recombinant Didelphis marsupialis virginiana MT-ATP8 could contribute significantly to this field:

  • Proof-of-concept for small mitochondrial proteins: MT-ATP8's relatively small size (69 amino acids) makes it an ideal candidate for allotopic expression studies, potentially facing fewer import challenges than larger mitochondrial proteins.

  • Methodological framework for optimization:

    • Codon optimization for nuclear expression

    • Testing various mitochondrial targeting sequences for efficient import

    • Optimization of protein expression levels to prevent aggregation

    • Assessment of proper integration into the ATP synthase complex

  • Cross-species compatibility testing: Success with recombinant opossum MT-ATP8 could inform approaches for human applications, particularly given the evolutionary distance between marsupials and placental mammals.

  • Therapeutic model development: Building on successful mouse models where allotopically expressed ATP8 was "constitutively expressed across all tested tissues, successfully transported into the mitochondria, and incorporated into ATP synthase" .

Researchers have demonstrated that allotopically expressed ATP8 protein can be successfully integrated into functional ATP synthase complexes without negative impacts on mitochondrial function, metabolism, or organismal physiology . This suggests potential for therapeutic applications in addressing MT-ATP8 defects through gene therapy approaches.

How do experimental approaches for studying MT-ATP8 differ from those used for other ATP synthase subunits?

MT-ATP8 presents unique experimental challenges compared to other ATP synthase subunits due to several distinguishing characteristics:

These methodological differences require researchers to employ integrated approaches that combine biochemical, genetic, and structural techniques when studying MT-ATP8, often relying more heavily on model organisms and reconstitution experiments than would be necessary for larger, more soluble ATP synthase subunits.

What is known about MT-ATP8 variants and their association with disease?

mtDNA variantNumber of casesATP8 amino acid changeAssociated disease/syndromePathogenic score*Status: MITOMAP/ClinVar
8381A>G2T6AMIDD/LVNC cardiomyopathy0.47Reported/benign
8382C>T1T6IEpisodic paralysis0.58Reported/uncertain significance
8403T>C1I13TEpisodic weakness and progressive neuropathy0.77Reported/uncertain significance
8411A>G1M16VSevere mitochondrial disorder0.63Reported/uncertain significance

*Pathogenic scores based on computational prediction algorithms

These clinical findings highlight the importance of conserved residues in the N-terminal region of MT-ATP8. Experimental models, including yeast systems, have been employed to study the biochemical effects of these variants. For example, the m.8403T>C variant (I13T) has been specifically investigated using yeast models, with biochemical data from yeast mitochondria suggesting that this equivalent mutation is not severely detrimental to enzyme function . This illustrates the complexity of interpreting the clinical significance of MT-ATP8 variants and underscores the need for functional studies to complement genetic findings.

How does studying Didelphis marsupialis virginiana MT-ATP8 contribute to understanding mitochondrial genome evolution?

Research on Didelphis marsupialis virginiana MT-ATP8 provides valuable insights into several aspects of mitochondrial genome evolution:

  • Nuclear integration of mitochondrial genes: The genus Didelphis shows evidence of multiple independent events of mtDNA migration to the nuclear genome, creating a natural laboratory for studying this evolutionary process . Analyses of these nuclear mitochondrial DNA segments (NUMTs) in Didelphis species reveal that "mtDNA migration to the nuclear genome occurred more than once in Didelphis evolution" .

  • Sequence evolution rates: Comparing authentic mitochondrial MT-ATP8 sequences with their nuclear counterparts allows researchers to quantify the different selective pressures acting on the same genetic sequence in different cellular compartments. Transition/transversion ratios and patterns of nucleotide substitutions differ significantly between mitochondrial and nuclear copies .

  • Functional constraints: The conservation pattern of MT-ATP8 across marsupials provides insights into which regions of the protein are under strongest functional constraint. This information complements structural studies and helps identify critical functional domains.

  • Compensatory evolution: Studying co-evolution of MT-ATP8 with other ATP synthase subunits across species enables identification of compensatory mutations that maintain protein-protein interfaces despite sequence changes.

  • Genetic code evolution: The different genetic codes used in mitochondrial versus nuclear genomes create interesting evolutionary scenarios when genes transfer between compartments. Studying these cases in Didelphis provides insights into mechanisms of genetic code adaptation.

These evolutionary insights from Didelphis MT-ATP8 research contribute to broader understanding of mitochondrial gene evolution and the ongoing genetic exchange between organellar and nuclear genomes in eukaryotes.

What therapeutic potential exists for targeting MT-ATP8 in mitochondrial disease research?

Research into MT-ATP8 has revealed several promising therapeutic avenues for addressing mitochondrial diseases associated with defects in this protein:

  • Allotopic expression therapy: The most direct approach involves expressing functional MT-ATP8 from the nuclear genome. Research has demonstrated that:

    • Codon-optimized nuclear versions of MT-ATP8 can be successfully expressed

    • The protein can be effectively targeted to mitochondria

    • Nuclear-expressed MT-ATP8 properly incorporates into the ATP synthase complex

    • Functional rescue of defects is possible with this approach

    Long-term studies in transgenic mice have shown that "allotopically expressed ATP8 protein had no negative impact on measured mitochondrial function, metabolism, or behavior" , suggesting safety for therapeutic applications.

  • Small molecule modulators: Based on structural understanding of MT-ATP8's role in the ATP synthase complex, targeted small molecules might:

    • Stabilize mutant MT-ATP8 proteins

    • Enhance interactions with partner subunits

    • Promote proper assembly of the ATP synthase complex

  • Peptide-based therapeutics: Synthetic peptides mimicking functional domains of MT-ATP8 could potentially:

    • Compete with dysfunctional domains of mutant proteins

    • Restore critical protein-protein interactions

    • Stabilize the proton-conducting apparatus

  • Gene editing approaches: While challenging for mitochondrial genes, advances in mitochondrially-targeted nucleases might eventually allow direct repair of MT-ATP8 mutations within mitochondria.

The successful demonstration that a "transgenic mouse model that expresses an epitope-tagged and codon-optimized ATP8 mitochondrial gene" can maintain expression "across tissues, over time, and is faithfully transmitted to the progeny for up to four generations" represents a significant advancement in the field and suggests that similar approaches could be viable for human therapeutic development.

What are the key considerations for storage and handling of recombinant MT-ATP8 protein?

Proper storage and handling of recombinant Didelphis marsupialis virginiana MT-ATP8 protein is critical for maintaining its structural integrity and functional properties. Based on established protocols, researchers should consider the following guidelines:

  • Initial preparation:

    • Centrifuge the vial briefly before opening to bring contents to the bottom

    • Reconstitute lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Storage buffer optimization:

    • Use Tris/PBS-based buffer with 6% Trehalose, pH 8.0

    • Add glycerol to a final concentration of 5-50% (50% is recommended) as a cryoprotectant

  • Aliquoting strategy:

    • Divide into small working aliquots immediately after reconstitution

    • Use low-protein-binding microcentrifuge tubes

    • Minimize freeze-thaw cycles as repeated freezing and thawing is not recommended

  • Storage conditions:

    • Store working aliquots at 4°C for up to one week

    • Store long-term aliquots at -20°C/-80°C

    • Maintain consistent storage temperature to prevent protein degradation

  • Handling during experiments:

    • Always keep the protein on ice when working at the bench

    • Include protease inhibitors in working solutions

    • Avoid vigorous vortexing which can cause protein denaturation

    • Consider adding mild detergents or lipids for stabilization of this membrane protein

These storage and handling considerations are essential for ensuring experimental reproducibility and obtaining reliable results when working with this challenging membrane protein.

How can researchers overcome challenges in functional characterization of MT-ATP8?

Functional characterization of MT-ATP8 presents several technical challenges due to its small size, hydrophobicity, and integral role within the larger ATP synthase complex. Researchers can implement the following methodological strategies to overcome these limitations:

  • Reconstitution systems:

    • Incorporate purified recombinant MT-ATP8 into liposomes with other essential ATP synthase subunits

    • Utilize nanodiscs with defined lipid composition to maintain native-like membrane environment

    • Develop minimal functional units containing only essential subunits for specific functional assays

  • Advanced imaging approaches:

    • Apply single-molecule FRET to detect conformational changes during ATP synthesis

    • Utilize super-resolution microscopy to visualize MT-ATP8 within the ATP synthase complex

    • Employ cryo-electron microscopy with improved detectors to better resolve this small subunit

  • Genetic complementation strategies:

    • Use yeast models with deleted or modified ATP8 genes to test functional complementation by the opossum protein

    • Develop mammalian cell lines with controlled expression of mutant and wild-type MT-ATP8 variants

  • Functional proxies:

    • Measure membrane potential as an indirect indicator of proton translocation

    • Assess ATP synthase assembly efficiency as a readout for MT-ATP8 function

    • Monitor reactive oxygen species production as an indicator of compromised ATP synthase function

  • Computational modeling integration:

    • Build molecular dynamics simulations to predict functional impacts of specific residues

    • Use evolutionary coupling analysis to identify functionally linked residue networks

    • Apply machine learning approaches to integrate multiple data types for functional prediction

These approaches collectively provide a comprehensive toolkit for elucidating MT-ATP8 function despite the technical challenges inherent to this small mitochondrial protein.

What considerations are important when designing experiments to study the integration of MT-ATP8 into the ATP synthase complex?

Investigating the integration of MT-ATP8 into the ATP synthase complex requires careful experimental design to account for the complex assembly process and membrane environment. Researchers should consider the following methodological approaches:

  • Temporal resolution of assembly:

    • Implement pulse-chase experiments with radioactive or fluorescent labeling

    • Use inducible expression systems to control timing of MT-ATP8 production

    • Apply time-resolved crosslinking to capture intermediate assembly states

  • Spatial tracking:

    • Utilize split fluorescent proteins to visualize MT-ATP8 interaction with partner subunits

    • Employ proximity labeling techniques (BioID, APEX) to identify transient interaction partners

    • Use subcellular fractionation combined with immunodetection to track localization during assembly

  • Structural verification:

    • Apply blue native PAGE to analyze intact complexes containing tagged MT-ATP8

    • Use chemical crosslinking coupled with mass spectrometry to map interaction interfaces

    • Implement hydrogen-deuterium exchange mass spectrometry to detect conformational changes

  • Functional validation:

    • Measure ATP synthesis rates in reconstituted systems with and without MT-ATP8

    • Assess proton translocation efficiency using pH-sensitive fluorescent probes

    • Evaluate complex stability under varying conditions (temperature, pH, ionic strength)

  • Model system selection:

    • Consider yeast as a genetically tractable system for studying assembly mechanisms

    • Evaluate mammalian cell models for more direct relevance to opossum protein

    • Explore bacterial expression systems for simplified assembly studies

  • Technical controls:

    • Include proper epitope tags that minimally interfere with assembly

    • Verify that protein modifications do not disrupt critical interaction interfaces

    • Compare results across multiple detection methods to ensure reliability

What emerging technologies might advance our understanding of MT-ATP8 structure and function?

Several cutting-edge technologies are poised to revolutionize our understanding of MT-ATP8's structure and function in the coming years:

The combination of these technologies will provide unprecedented insights into how this small but essential protein contributes to the ATP synthase molecular machine.

How might comparative studies across marsupial species enhance our understanding of MT-ATP8 evolution and function?

Comparative studies across marsupial species represent a powerful approach for elucidating both the evolutionary history and functional constraints of MT-ATP8:

  • Functional constraint mapping:

    • Sequence comparison across diverse marsupials can identify ultra-conserved residues under strong purifying selection

    • Correlation of conservation patterns with structural features reveals functionally critical domains

    • Natural variation provides insights into which regions tolerate substitutions

  • Adaptive evolution detection:

    • Identification of lineage-specific positive selection may reveal adaptation to different energetic demands

    • Correlation of amino acid changes with ecological or physiological traits across marsupials

    • Detection of co-evolving sites between MT-ATP8 and other ATP synthase subunits

  • Nuclear transfer dynamics:

    • Comparative analysis of nuclear MT-ATP8-like sequences across marsupials can reveal the timing and frequency of mitochondrial-to-nuclear gene transfer events

    • Assessment of selection pressures on nuclear copies compared to mitochondrial counterparts

    • Investigation of potential functional roles of nuclear copies

  • Structure-function relationship refinement:

    • Correlation of natural sequence variation with biochemical properties across species

    • Identification of compensatory mutations that maintain function despite primary sequence changes

    • Recognition of convergent evolution patterns indicating functional constraints

  • Experimental validation opportunities:

    • Testing functional equivalence of MT-ATP8 proteins from different marsupial species through cross-species complementation

    • Investigating chimeric proteins to isolate functionally distinct domains

    • Comparing biochemical properties of recombinant MT-ATP8 from different species

Such comparative approaches across marsupials would complement the detailed molecular studies of Didelphis marsupialis virginiana MT-ATP8 and provide evolutionary context for interpreting functional data.

What potential exists for using MT-ATP8 research to address broader questions in mitochondrial biology?

Research on Didelphis marsupialis virginiana MT-ATP8 has implications that extend far beyond this specific protein, potentially addressing fundamental questions in mitochondrial biology:

  • Mitochondrial-nuclear genomic coordination:

    • Investigation of how nuclear-encoded ATP synthase subunits co-evolve with mitochondrially-encoded MT-ATP8

    • Understanding communication mechanisms between organellar and nuclear genomes

    • Exploring the consequences of mito-nuclear mismatch through experimental models

  • Organellar gene transfer mechanisms:

    • The documented transfer of MT-ATP8-like sequences to the nuclear genome in Didelphis provides a natural model for studying the mechanisms and consequences of organellar gene transfer

    • Understanding the process of functional gene transfer requires addressing import, expression, and assembly challenges

  • Therapeutic strategy development:

    • Successful allotopic expression of ATP8 demonstrates a potential therapeutic approach for mitochondrial diseases

    • The finding that "the allotopically expressed ATP8 protein in transgenic mice was constitutively expressed across all tested tissues, successfully transported into the mitochondria, and incorporated into ATP synthase" provides proof-of-principle for similar approaches with other mitochondrial genes

  • Energy metabolism adaptations:

    • Comparative study of MT-ATP8 across species with different metabolic demands may reveal adaptations in energy production

    • Understanding how ATP synthase activity is regulated in different physiological contexts

  • Aging and mitochondrial dysfunction:

    • Investigation of how MT-ATP8 mutations or variations contribute to age-related decline in mitochondrial function

    • Development of interventions targeting ATP synthase function as potential approaches to address aging-related mitochondrial dysfunction

  • Evolutionary cell biology insights:

    • The study of MT-ATP8 evolution provides insights into the broader question of why some genes remain in the mitochondrial genome while others have been transferred to the nucleus

    • Understanding the constraints that prevent complete transfer of mitochondrial genes to the nucleus

These broader implications demonstrate how focused research on MT-ATP8 from Didelphis marsupialis virginiana contributes to fundamental questions in mitochondrial biology, evolution, and translational research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.